Skip to main content

KV Pharmaceuticals Case 04/08/2008

  • If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

<p>St. Louis-based KV Pharmaceuticals Inc. said on Monday that a settlement was reached. in the shareholders derivative lawsuit. The shareholders derivative lawsuit was filed over KV Pharmaceuticals Inc.’s directors options granting practices. KV Pharmaceuticals Inc. did not disclose the amount of the settlement, but said it expected insurance to cover the fees and costs, and wi...



You must register (for free) or login to view the entire case.